Nowtransit Past Earnings Performance
Past criteria checks 0/6
Nowtransit has been growing earnings at an average annual rate of 1.2%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 731.2% per year.
Key information
1.2%
Earnings growth rate
81.8%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 731.2% |
| Return on equity | -203.9% |
| Net Margin | -27.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Nowtransit makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1 | 0 | 1 | 0 |
| 31 Dec 23 | 1 | 0 | 1 | 0 |
| 30 Sep 23 | 0 | 0 | 1 | 0 |
| 30 Jun 23 | 0 | 0 | 0 | 0 |
| 31 Mar 23 | 0 | 0 | 0 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
Quality Earnings: NOTR is currently unprofitable.
Growing Profit Margin: NOTR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if NOTR's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare NOTR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NOTR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.1%).
Return on Equity
High ROE: NOTR has a negative Return on Equity (-203.87%), as it is currently unprofitable.